13 Jun 2017
The investigational SGLT-2 inhibitor ertugliflozin improves glycaemic control in adults with type 2 diabetes, according to research presented at the American Diabetes Association Meeting in San Diego.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024